Unlocking the Value of Genomic Data
N-of-One is a clinical interpretation platform that provides evidence-based, patient-specific therapeutic and clinical trial options for commercial labs and health systems seeking to discern the actionable information buried within reams of molecular data. The company’s platform consistently provides undisputed best-in-class clinical interpretation.
Date of investment: 2016
Sector: Clinical Decision Support
Company status: Exited in 2019 (acquired by QIAGEN [NYSE: QGEN])
Associated team: Jeff Stolte
